Reinhart Partners LLC. Lowers Stock Position in Encompass Health Co. (NYSE:EHC)

Reinhart Partners LLC. lessened its holdings in Encompass Health Co. (NYSE:EHC) by 2.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 656,320 shares of the company’s stock after selling 16,720 shares during the quarter. Encompass Health accounts for about 2.3% of Reinhart Partners LLC.’s holdings, making the stock its 18th biggest position. Reinhart Partners LLC. owned approximately 0.65% of Encompass Health worth $60,611,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of EHC. Oliver Luxxe Assets LLC raised its position in shares of Encompass Health by 4.8% during the 4th quarter. Oliver Luxxe Assets LLC now owns 63,453 shares of the company’s stock worth $5,860,000 after purchasing an additional 2,900 shares during the last quarter. Nordea Investment Management AB increased its holdings in shares of Encompass Health by 5.2% during the 4th quarter. Nordea Investment Management AB now owns 94,514 shares of the company’s stock worth $8,797,000 after buying an additional 4,714 shares during the last quarter. Central Pacific Bank Trust Division increased its holdings in shares of Encompass Health by 15.1% during the 4th quarter. Central Pacific Bank Trust Division now owns 3,195 shares of the company’s stock worth $295,000 after buying an additional 418 shares during the last quarter. Everence Capital Management Inc. acquired a new stake in shares of Encompass Health during the 4th quarter worth $253,000. Finally, GAMMA Investing LLC increased its holdings in shares of Encompass Health by 22.1% during the 4th quarter. GAMMA Investing LLC now owns 1,947 shares of the company’s stock worth $180,000 after buying an additional 352 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. UBS Group upped their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, September 25th. KeyCorp raised their price target on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Royal Bank of Canada raised their price target on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Barclays raised their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Finally, Truist Financial restated a “buy” rating and set a $116.00 target price (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Nine research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Stock Up 0.6 %

EHC stock traded up $0.57 during midday trading on Monday, reaching $91.62. The company had a trading volume of 117,168 shares, compared to its average volume of 570,823. Encompass Health Co. has a 1 year low of $67.94 and a 1 year high of $104.55. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $9.23 billion, a P/E ratio of 22.13, a PEG ratio of 1.30 and a beta of 0.89. The company has a 50 day moving average of $98.23 and a two-hundred day moving average of $93.78.

Encompass Health (NYSE:EHC) last released its earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter in the prior year, the firm earned $0.86 EPS. The company’s revenue was up 11.9% compared to the same quarter last year. On average, equities research analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.74%. Encompass Health’s dividend payout ratio is currently 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.